Dietary clenbuterol modifies the expression of genes involved in the regulation of lipid metabolism and growth in the liver, skeletal muscle, and adipose tissue of Nile tilapia (Oreochromis niloticus)

The current study aimed to evaluate whether clenbuterol, a β2-adrenergic agonist, supplementation in Nile tilapia (Oreochromis niloticus) diets can influence growth and blood parameters. Besides, assessment of adipogenic genes as fatty acid synthase (FAS) and lipoprotein lipase (LPL) which is a key enzyme in the regulation of the flux of fatty acids in liver, muscle, and adipose tissue as well as muscle growth-regulating genes as myostatin (MYO) in muscle and insulin-like growth factor-1 (IGF-1) in liver. The fish were allocated into three equal groups; control group that fed basal diet only and the other two groups fed a basal diet containing clenbuterol at two doses 5 ppm and 10 ppm/kg diet for 30 consecutive days. Results revealed that clenbuterol supplementation significantly increased body weight, decreased liver, spleen and abdominal fat weights, and decreased total circulatory cholesterol and triacylglycerol levels. Moreover, clenbuterol inhibits lipogenesis by downregulation of FAS gene expression by dose and time-dependent manner in the liver while enhanced lipolysis in both the liver and in the adipose tissue. Moreover, lipolysis was reduced in muscle by dose 10 ppm on day 30. Furthermore, clenbuterol presented higher gene expression of MYO and IGF-1 in muscle and liver respectively by dose 5 ppm at day 15 on the other hand, these findings were reversed by day 30 compared with control. In conclusion, clenbuterol efficacy was apparent in a dose and time response pattern to boost growth and reduce fat deposition rates, indicating for the first time that clenbuterol has a profitable growth impact on Nile tilapia

Impact of nucleotide enriched diets on the production of gilthead seabream, Sparus aurata fingerlings by modulation of liver mitochondrial enzyme activitity, antioxidant status, immune gene expression, and gut microbial ecology

Systematic reproduction and distribution, duplication of any material in this paper for a fee or for commercial purposes, or modifications of the content of this paper are prohibited.[EN] The objective of this study was to evaluate the effect of fish meal replacement with a mixture of plant, and animal protein supplemented with a commercial nucleotide NucleofomeFish (TM), on growth, feed utilization, whole-body composition, biometric indices; liver mitochondrial enzyme activities, selected gene expression and influence on the gut micmbiome of gilthead seabream, Sparus aurata. Six hundred and thirty gilthead seabream with an average initial body weight of 0.358 +/- 0.002 g/fish, were used. Six experimental diets were formulated to be isonitrogenous, 45% crude protein (CP) and isocaloric 20 MJ/kg gross energy (GE). The control diet (Dl) contained 25% of fish meal (FM25) and had no NucleoforceFish (TM) added (FM25/0), diets 2-3 contained FM at a level of 25% and supplemented with 250 (FM25/250) and 500 (FM25/500) mg/kg NucleoforceFish (TM), respectively. Diets 4-6 were a non-fishmeal formulation and had no NucleoforceFish (TM), (diet 4, FM0/0), 0%FM with 250mg/kg NucleoforceFish (TM) (diet 5, FM0/250), and 0%FM with 500mg/kg NucleofomeFish (TM) (diet 6, FM0/500). The results revealed that dietary nucleotides supplemented at 250mg/kg or 500mg/kg enhanced final body weight, weight gain, and specific growth rate of seabream either with dietary level of 25% FM diet (FM25) or non-fishmeal diet (FM0). All mitochondrial liver complex enzyme activities were recorded as having a significant positive response to the nucleotide dietary supplement. Gilthead seabream fingerlings fed FM0/250 diet for 150 days had significantly elevated liver mitochondrial enzyme (Complex III, Complex IV, Complex I and II) activities. In addition, gilthead seabream fed FM(0/500 )had significantly increased the gene expression of TCR-B and IL1-B, while fish fed FM25/250 increased significantly the gene expression of IGF1, while fish fed FM(25/500 )increased significantly the gene expression of Hepcidin (Hep) and the iron homeostasis hormone. There was a marked influence on specific bacteria comprising the gut microbiome namely Photobacterium; damselae; Vibrio anguillarum; Lactobacillus plantarum; Lactobacillus Enterococcus faecium subtilis. It can be concluded that FM25/250 and FM25/500 diets are expressing the best result, which explains that FM must be in the feed of gilthead seabream, and addition of NucleoforceFish (TM) at 250 mg/kg feed may further increase the performance.El-Nokrashy, AM.; El-Banna, R.; Edrise, B.; Abdel-Rahim, M.; Jover Cerda, M.; Tomas-Vidal, A.; Prince, A.... (2021). Impact of nucleotide enriched diets on the production of gilthead seabream, Sparus aurata fingerlings by modulation of liver mitochondrial enzyme activitity, antioxidant status, immune gene expression, and gut microbial ecology. Aquaculture. 535:1-13. https://doi.org/10.1016/j.aquaculture.2021.736398S11353

Effects of exogenous bile acids (BAs) on growth, lipid profile, digestive enzymes, and immune responses of thinlip mullet, Liza ramada

Abstract An eight-week trial was designed to explore the dietary effects of commercially purchased exogenous bile acids (BAs) on growth, whole-body composition, lipid profile, intestinal digestive enzymes, liver function enzymes, oxidative stress biomarkers, and serum immunity of thinlip mullet, Liza ramada. Four triplicate groups (10.50 ± 0.05 g) were fed four soybean meal (SBM)-based diets supplied with several BAs levels at 0 (control), 50, 130, or 350 mg/kg feed. Results indicated that the growth was significantly increased in groups fed BAs-based diets, especially at 130 mg/kg feed. The body composition analysis showed that feeding fish on diets supplied with BAs up to 130 mg/kg decreased moisture (%) alongside increased crude protein (%). However, the body composition of fish fed a diet with 350 mg BAs/kg had the lowest moisture (%) and the highest crude protein (%). Moreover, there were significant increases in the intestinal (protease, α-amylase, and lipase) enzyme activities in the groups supplied with BAs up to 130 mg BAs/kg. Liver function enzymes (aspartate aminotransferase and alanine aminotransferase enzyme activities) were significantly decreased in BAs-supplemented groups compared to those fed the BAs-free group. On the other hand, the control group had higher total cholesterol, triglycerides, and low-density lipoprotein alongside the lower high-density lipoprotein than BAs-supplemented groups, especially at 350 mg BAs/kg feed. BAs significantly decreased hepatic malondialdehyde concentrations and increased the activity of hepatic catalase, superoxide dismutase, and total antioxidant capacity compared with those reared on the control diet. Serum lysozyme, respiratory burst, and alternative complement activities were significantly increased in BAs-supplied groups, particularly in the group supplied with 130 mg BAs/kg compared to those fed on the control diet. Accordingly, our findings recommend that including 130 mg BAs/kg in an SBM-based diet enhanced the growth, digestive enzyme activities, and liver functions, alleviated oxidative stress, boosted serum immunity, and lowered lipid metabolites in thinlip mullet. These findings will be beneficial for improving the quality of feed prepared for feeding mullets and an effective alternative strategy to support mullet farming